MedPath

Short-term Telehealth Follow up After Hospital Discharge for Chronic Obstructive Pulmonary Disease Exacerbation

Not Applicable
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Procedure: Telemonitoring
Registration Number
NCT01489241
Lead Sponsor
Regional Health Authority of Sterea & Thessaly
Brief Summary

The purpose of this study is to evaluate whether the introduction of a short-term telemonitoring program for chronic obstructive pulmonary disease (COPD) patients discharged from the hospital after disease exacerbation produces benefits in terms of a reduction in hospital readmissions and health related quality of life. In addition the trials evaluate the economical and organisational impact of the services and examine their acceptability by patients and health professionals.

Detailed Description

The purpose of this study is to the evaluate the use of a close phone-based tele-monitoring platform will reflected by less hospital re-admissions, will change their generic and disease specific quality of life compared with usual care. Following this; it is also hypothesized that this will also lead to less patients' deaths. In addition the patients' satisfaction using the telemedicine service will be studied. A Cost-Effective Analysis will evaluate the tele-health service compared with the usual care from the health and social perspective.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
155
Inclusion Criteria
  • Exacerbation of COPD according to the GOLD guidelines
  • Age > 40 years
  • Capability to use the devices provided
  • Willing to participate
Exclusion Criteria

included in previous COPD monitoring study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TelemonitoringTelemonitoring-
Primary Outcome Measures
NameTimeMethod
Number of hospital readmissions3 months period

Number of hospital readmissions after the hospital discharged of the patient after a COPD exacerbation

Secondary Outcome Measures
NameTimeMethod
Health related quality of life of the patients as measured by the SF-36 version 2 questionnaire3 months - at the entry point of the intervention and the end.

Health related quality of life of the patients as measured by the SF-36 version 2 questionnaire

Hospital anxiety and depression scale HADS3 months - at the entry point of the intervention and the end.

Hospital anxiety and depression scale HADS

Health status, measured with the St. George's Respiratory Questionnaire SGRQ3 months - at the entry point of the intervention and the end.

Health status, measured with the St. George's Respiratory Questionnaire SGRQ

Lung condition as measured by FEV11 month after the hospital discharge.

Lung condition as measured by FEV1

Mortality3 months period

Mortality

Patients' Acceptance-Satisfaction measured by the WSD Questionnaireat the 3rd month of the tele-monitoring

Patients' Acceptance-Satisfaction of telemonitoring measured by the Whole System Demonstrators Questionnaire , for the intervention arm (telemonitoring)

Trial Locations

Locations (1)

Pulmonary Department - Regional University Hospital of Larisa

🇬🇷

Larisa, Thessaly, Greece

© Copyright 2025. All Rights Reserved by MedPath